Anti-HIV-1 Vpr Intrabody [+36GFP] (IAB-B054(G))
Recombinant anti-HIV-1 Vpr intrabody in fusion with +36GFP works within cells and is directed against HIV-1 Vpr, expressed in CHO cells. It is able and is directed against the HIV-1 regulatory Vpr protein in the cytoplasm of eukaryotic cells, leading to its delocalization from the nucleus to the cytoplasm.
Specifications
- Immunogen
- human papillomavirus Vpr
- Host
- llama
- Type
- vhh-(+36GFP)
- Cell Penetrating Peptide
- +36 GFP
GFP with a theoretical net charge of +36 (+36 GFP) penetrated several different mammalian cell lines at very low (nanomolar) concentrations. Cationic peptides and proteins have been observed to penetrate cells, and both natural and synthetic cell-penetrating peptides are widely used as delivery vehicles. However, whereas a covalent link between the cell-penetrating peptide and its cargo is typically required.
- Species Reactivity
- HIV-1
- Applications
- Antibody assay: Immunocytochemistry; Neutralization; Functional studies
Target
- Alternative Names
- HIV-1 Vpr; human papillomavirus Vpr
- Entrez Gene ID
- 155807
For lab research use only, not for diagnostic, therapeutic or any in vivo human use.
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email: